Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics.
Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, Purdom E, Dudoit S.
BMC Genomics. 2018 Jun 19;19(1):477. doi: 10.1186/s12864-018-4772-0.
Neural signature of inattentional deafness.
Durantin G, Dehais F, Gonthier N, Terzibas C, Callan DE.
Hum Brain Mapp. 2017 Nov;38(11):5440-5455. doi: 10.1002/hbm.23735. Epub 2017 Jul 26.
Nonorganic Functional Hearing Loss.
Hussain SAS, Hohman MH.
2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Atomistic mechanisms of the regulation of small-conductance Ca2++ channel (SK2) by PIP2.
Woltz RL, Zheng Y, Choi W, Ngo K, Trinh P, Ren L, Thai PN, Harris BJ, Han Y, Rouen KC, Mateos DL, Jian Z, Chen-Izu Y, Dickson EJ, Yamoah EN, Yarov-Yarovoy V, Vorobyov I, Zhang XD, Chiamvimonvat N.
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2318900121. doi: 10.1073/pnas.2318900121. Epub 2024 Sep 17.
Relevance of connexin deafness (DFNB1) to human evolution.
Nance WE, Kearsey MJ.
Am J Hum Genet. 2004 Jun;74(6):1081-7. doi: 10.1086/420979. Epub 2004 Apr 9.
Exploring the application of stem cell technology in treating sensorineural hearing loss.
Li M, Ma R, Li Q, Guo M.
Am J Stem Cells. 2024 Aug 25;13(4):212-221. doi: 10.62347/AEIV5813. eCollection 2024.
Cochlear implants.
Michelson RP.
J Laryngol Otol. 1976 May;90(5):441-4. doi: 10.1017/s0022215100082293.
A cost-effectiveness analysis of pre-pregnancy genetic screening for deafness: an empirical study in China.
Lv Y, Wang Z, Yuan L, Cheng F, Wu H, Wang Z, Yang T, Chen Y.
Front Public Health. 2023 Dec 7;11:1081339. doi: 10.3389/fpubh.2023.1081339. eCollection 2023.
Dracula's teeth syndrome.
Jacome DE.
Headache. 2001 Oct;41(9):892-4.
Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss.
Liao Y, Mao H, Gao X, Lin H, Li W, Chen Y, Li H.
Free Radic Biol Med. 2024 Jan;210:430-447. doi: 10.1016/j.freeradbiomed.2023.11.025. Epub 2023 Dec 5.
